Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Hoya purchase = lower share price

Re: Hoya purchase = lower share price...that was right in the past!

posted on Jun 30, 2008 09:12AM

I think it's because the releases are more of the same. It's a case of "no new news is bad news." Another license but no mention of phase II or whatever else shareholders are looking for.

I agree with fatwollit (I think it was) that only good dollar figures and/or the Patent Office can move this upward.

Since TPL/PTSC refuse to announce dollar figures (and understandably so, if confidentiality is the license agreement), these news releases do nothing positive.

Also, Hoya can't have all that many infringing products. If I read it right, they're an optical lens/glass company.

Share
New Message
Please login to post a reply